LENSAR, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LENSAR, Inc. (Nasdaq: LNSR) on January 13, 2023, covering events that occurred on January 11, 2023. The Company is incorporated in Delaware and is designated as an emerging growth company.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on executive compensation adjustments.
Material Changes
On January 11, 2023, the Board of Directors approved the following compensatory arrangements for Chief Executive Officer Nicholas T. Curtis, Chief Financial Officer Alan B. Connaughton, and Chief Technology Officer Thomas R. Staab, II:
- Cash Bonuses: Annual cash bonuses for 2022 were approved at 90% of each officer's annual target bonus.
- Base Salary Increase: A 4.5% increase in base salary for each officer, effective January 9, 2023.
- Equity Grants: Grants of stock options and restricted stock units (RSUs) under the 2020 Incentive Award Plan.
Equity Grant Details
| Officer Name | Stock Options Granted | RSUs Granted |
|---|---|---|
| Nicholas T. Curtis | 77,651 | 22,186 |
| Alan B. Connaughton | 54,356 | 15,530 |
| Thomas R. Staab, II | 23,295 | 6,656 |
Terms: Options have an exercise price of $2.65 per share (fair market value on grant date). Options vest 25% on the one-year anniversary and the remainder in 36 monthly installments. RSUs vest 25% on each anniversary of the grant date.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on business outlook, or disclosures regarding new risks or contingencies beyond the standard executive compensation disclosure.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2020 Incentive Award Plan to assess remaining capacity for future grants.
- Review the Company's most recent 10-K or 10-Q to understand the impact of the 4.5% salary increase and bonus payments on operating expenses.
- Confirm the vesting schedule alignment with the Company's strategic milestones or performance goals.
- Check the current trading price of LNSR relative to the $2.65 option exercise price to evaluate the intrinsic value of the grants.